114 related articles for article (PubMed ID: 8534929)
21. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
Kato T; Sato K; Kakinuma H; Matsuda Y
Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956
[TBL] [Abstract][Full Text] [Related]
22. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
[TBL] [Abstract][Full Text] [Related]
23. [Inhibitory effect of fumagillol combined with cyclophosphamide on metastasis of lung adenocarcinoma cell line LA795 xenograft in mice].
Wang XH; Wang Z; Duan BC; Song JT; He JB; Ou LW; Zhang P
Ai Zheng; 2005 Dec; 24(12):1448-52. PubMed ID: 16351790
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
25. Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma.
Tofani S; Barone D; Berardelli M; Berno E; Cintorino M; Foglia L; Ossola P; Ronchetto F; Toso E; Eandi M
Pharmacol Res; 2003 Jul; 48(1):83-90. PubMed ID: 12770519
[TBL] [Abstract][Full Text] [Related]
26. CAI: effects on cytotoxic therapies in vitro and in vivo.
Teicher BA; Holden SA; Chen YN; Ara G; Korbut TT; Northey D
Cancer Chemother Pharmacol; 1994; 34(6):515-21. PubMed ID: 7923563
[TBL] [Abstract][Full Text] [Related]
27. Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents.
Teicher BA; Holden SA; Ara G; Northey D
Anticancer Res; 1993; 13(6A):2101-6. PubMed ID: 7507654
[TBL] [Abstract][Full Text] [Related]
28. Cyclocreatine in cancer chemotherapy.
Teicher BA; Menon K; Northey D; Liu J; Kufe DW; Kaddurah-Daouk R
Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model.
Sigounas G; Sallah S; Sigounas VY
Cancer Lett; 2004 Oct; 214(2):171-9. PubMed ID: 15363543
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T
Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930
[TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide.
Wietrzyk J; Boratynski J; Grynkiewicz G; Ryczynski A; Radzikowski C; Opolski A
Anticancer Res; 2001; 21(6A):3893-6. PubMed ID: 11911265
[TBL] [Abstract][Full Text] [Related]
32. Combination of angiogenesis inhibitor TNP-470 with cytotoxic drugs in experimental therapy of nasopharyngeal carcinoma.
Qian CN; Min HQ; Lin HL; Hong MH
Ann Otol Rhinol Laryngol; 2000 Jul; 109(7):641-5. PubMed ID: 10903044
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing.
Klein SA; Bond SJ; Gupta SC; Yacoub OA; Anderson GL
J Surg Res; 1999 Apr; 82(2):268-74. PubMed ID: 10090839
[TBL] [Abstract][Full Text] [Related]
34. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma.
Zhang Q; Kang X; Zhao W
Biochem Biophys Res Commun; 2006 Apr; 342(3):824-8. PubMed ID: 16499874
[TBL] [Abstract][Full Text] [Related]
35. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies.
Teicher BA; Liu SD; Liu JT; Holden SA; Herman TS
Anticancer Res; 1993; 13(5A):1549-56. PubMed ID: 8239534
[TBL] [Abstract][Full Text] [Related]
36. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
37. [Minocycline potentiates the antimetastatic effect of boanmycin].
Liu JG; Jiang M; Xu LN; Zhen YS
Yao Xue Xue Bao; 1995; 30(9):668-73. PubMed ID: 8701742
[TBL] [Abstract][Full Text] [Related]
38. [Cancer therapy targeting tumor-induced neovascularization].
Sato K; Kato T
Gan To Kagaku Ryoho; 1994 Feb; 21(3):295-300. PubMed ID: 7509149
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.
Yamaoka M; Yamamoto T; Ikeyama S; Sudo K; Fujita T
Cancer Res; 1993 Nov; 53(21):5233-6. PubMed ID: 7693335
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
